Markets.com Logo

BHVN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    14.6931$
  • Previous Close
    14.6436$
  • 52 Week Change
    42.91$
  • Day Range
    0.05$
  • 52 Week High/Low
    12.79$ - 55.7$
  • Dividend Per Share
    --
  • Market cap
    1 555 M$
  • EPS
    -1.63
  • Beta
    3.498
  • Volume
    --

About

Biohaven Ltd. (BHVN.US), now part of Pfizer, was a biopharmaceutical company focused on developing and commercializing innovative therapies for neurological and neuropsychiatric diseases. Their primary product was Nurtec ODT (rimegepant), an oral CGRP receptor antagonist approved for both the acute treatment of migraine and the preventive treatment of episodic migraine in adults. Pfizer acquired Biohaven in 2022, retaining the Nurtec ODT and zavegepant assets, while a new publicly traded company, Biohaven NewCo (later renamed Channel Bio), was spun out with Biohaven's remaining research and development portfolio. The BHVN.US symbol now represents the historical value of Biohaven Ltd. before the acquisition and is no longer actively traded.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Clinical Trial Results: Positive or negative data from clinical trials for BHVN's investigational drugs significantly impacts investor confidence.

Regulatory Decisions: FDA approvals or rejections of BHVN's drugs directly affect its revenue potential and market value.

Competition: The presence of competing therapies or companies in the same therapeutic areas influences BHVN's market share and profitability.

Market Sentiment: Overall investor optimism or pessimism towards the biotechnology sector can affect BHVN's stock price.

Financial Performance: BHVN's revenue, expenses, and cash flow reflect its ability to fund research and development and achieve profitability, thus influencing stock value.

Partnerships and Collaborations: Agreements with other pharmaceutical companies can provide BHVN with resources and validation, impacting its stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--